NYSE:CLB Core Laboratories - CLB Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. $22.05 +0.09 (+0.41%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$21.91▼$22.5450-Day Range$20.08▼$26.5552-Week Range$13.19▼$34.08Volume267,235 shsAverage Volume363,680 shsMarket Capitalization$1.03 billionP/E Ratio53.78Dividend Yield0.18%Price Target$21.83 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Core Laboratories MarketRank™ ForecastAnalyst RatingHold1.50 Rating ScoreUpside/Downside1.0% Downside$21.83 Price TargetShort InterestBearish8.37% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.63Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth36.25%From $0.80 to $1.09 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.66 out of 5 starsOils/Energy Sector214th out of 244 stocksOil & Gas Field Services, Not Elsewhere Classified Industry18th out of 19 stocks 0.8 Analyst's Opinion Consensus RatingCore Laboratories has received a consensus rating of Hold. The company's average rating score is 1.50, and is based on no buy ratings, 2 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $21.83, Core Laboratories has a forecasted downside of 1.0% from its current price of $22.05.Amount of Analyst CoverageCore Laboratories has only been the subject of 2 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted8.37% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 10.6, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently increased by 4.61%, indicating that investor sentiment is decreasing. Previous Next 1.7 Dividend Strength Dividend YieldCore Laboratories has a dividend yield of 0.19%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 9.76%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.67% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLB. Previous Next 3.1 News and Social Media Coverage News SentimentCore Laboratories has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Core Laboratories this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for CLB on MarketBeat in the last 30 days. This is a decrease of -92% compared to the previous 30 days.MarketBeat Follows1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.42% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.44% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Core Laboratories are expected to grow by 36.25% in the coming year, from $0.80 to $1.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 53.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.10.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 53.78, which means that it is trading at a less expensive P/E ratio than the Oils/Energy sector average P/E ratio of about 85.00.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 5.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Core Laboratories (NYSE:CLB) StockCore Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the Reservoir Description segment and Production Enhancement segment. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.Read More Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Stock News HeadlinesMarch 31, 2023 | thestreet.comCore Laboratories N.V Stock To Go Ex-dividend Tomorrow (CLB)March 27, 2023 | finance.yahoo.comCORE LABORATORIES' FIRST QUARTER 2023 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M. CEST ON APRIL 27, 2023April 1, 2023 | Vantage Point (Ad)The Market Crash Shield is A.I.Are you using the best technology to dominate April markets? This A.I. has traders doubting their methods. Attend This Live (FREE) A.I. Market Training. March 25, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) Coverage Initiated by Analysts at StockNews.comMarch 3, 2023 | finance.yahoo.comCore Laboratories (CLB) Up 0.9% Since Last Earnings Report: Can It Continue?February 27, 2023 | finance.yahoo.comHere’s Why Core Laboratories N.V. (CLB) Outperformed in Q4February 7, 2023 | finance.yahoo.comCore Laboratories N.V. (NYSE:CLB) Q4 2022 Earnings Call TranscriptFebruary 2, 2023 | finance.yahoo.comCore Laboratories (CLB) Q4 2022 Earnings Call TranscriptApril 1, 2023 | Vantage Point (Ad)What’s At Stake In April is ShockingThe Fed will be meeting on a topic that could change trading forever, and the decision could come as soon as the end of April. But by taking the smartest approach now, you can help shield your assets and work toward your trading goals. Time, as always, is of the essence. Click on this link to see what you need to do right away. February 1, 2023 | msn.comCore Laboratories Q4 Non-GAAP EPS of $0.20 beats by $0.01., revenue of $127.58M misses by $2.54MFebruary 1, 2023 | finance.yahoo.comCORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS FROM CONTINUING OPERATIONSFebruary 1, 2023 | finance.yahoo.comCore Laboratories (CLB) Surpasses Q4 Earnings EstimatesJanuary 31, 2023 | msn.comCore Laboratories's Earnings: A PreviewJanuary 25, 2023 | finance.yahoo.comEarnings Preview: Core Laboratories (CLB) Q4 Earnings Expected to DeclineJanuary 17, 2023 | markets.businessinsider.comCore Laboratories To Redomesticate To USJanuary 17, 2023 | seekingalpha.comCore Labs plans to redomesticate to U.S. from NetherlandsJanuary 17, 2023 | finance.yahoo.comCORE LAB ANNOUNCES PROPOSED REDOMESTICATION TO THE UNITED STATESJanuary 5, 2023 | fool.comThe oil reservoir specialist listens to what the oil fields are saying about supplies.January 4, 2023 | finance.yahoo.comCORE LABORATORIES' FOURTH QUARTER 2022 WEBCAST AT 7:30 A.M. CST / 2:30 P.M. CET ON FEBRUARY 2, 2023January 2, 2023 | thestreet.comWhy Core Laboratories (CLB) Stock Is Down TodayDecember 17, 2022 | marketwatch.comThe Alopecia Market Size: Generate Revenue, Impact on Covid -19, Foreign Opportunity, Installation during period 2022 - 2028.December 14, 2022 | finance.yahoo.comShould You Hold Core Laboratories N.V. (CLB) for Long-Term?December 8, 2022 | finance.yahoo.comWhy ExxonMobil, Chevron, and Core Labs Stocks Popped TodayDecember 3, 2022 | finance.yahoo.comDo You Believe in the Growth Prospects of Core Laboratories N.V. (CLB)?November 25, 2022 | finance.yahoo.comCore Laboratories (CLB) Up 9.6% Since Last Earnings Report: Can It Continue?November 14, 2022 | finance.yahoo.comCore Laboratories Scores RS Rating Upgrade; Hits Key BenchmarkNovember 11, 2022 | finance.yahoo.comWhy Oil and Gas Stocks Rallied Today, and Why It Might ContinueSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Company Calendar Last Earnings2/02/2023Ex-Dividend for 3/6 Dividend2/10/2023Dividend Payable3/06/2023Today3/31/2023Next Earnings (Confirmed)4/26/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Oil & gas field services, not elsewhere classified Sub-IndustryN/A SectorOils/Energy Current SymbolNYSE:CLB CUSIPN/A CIK1000229 Webwww.corelab.com Phone(120) 420-3191FaxN/AEmployees3,600Year Founded1936Price Target and Rating Average Stock Price Forecast$21.83 High Stock Price Forecast$26.00 Low Stock Price Forecast$20.00 Forecasted Upside/Downside-1.0%Consensus RatingHold Rating Score (0-4)1.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.41 Trailing P/E Ratio53.78 Forward P/E Ratio27.56 P/E GrowthN/ANet Income$19.45 million Net Margins3.97% Pretax Margin6.12% Return on Equity15.98% Return on Assets4.93% Debt Debt-to-Equity Ratio0.91 Current Ratio2.05 Quick Ratio1.47 Sales & Book Value Annual Sales$489.73 million Price / Sales2.10 Cash Flow$0.96 per share Price / Cash Flow22.90 Book Value$4.07 per share Price / Book5.42Miscellaneous Outstanding Shares46,630,000Free Float46,438,000Market Cap$1.03 billion OptionableOptionable Beta2.65 Social Links Key ExecutivesLawrence V. BrunoChairman-Supervisory Board, President & CEOChristopher S. HillChief Financial Officer & Senior Vice PresidentMark Damian TattoliSecretary, Senior Vice President & General CounselKevin G. DanielsTreasurer, Chief Accounting Officer & VPJacobus SchoutenManaging DirectorKey CompetitorsHelix Energy Solutions GroupNYSE:HLXProPetroNYSE:PUMPSelect Energy ServicesNYSE:WTTRNational Energy Services ReunitedNASDAQ:NESRRPCNYSE:RESView All CompetitorsInstitutional OwnershipTruist Financial CorpSold 6,452 shares on 2/17/2023Ownership: 0.883%Personal Capital Advisors CorpBought 11,355 shares on 2/16/2023Ownership: 0.024%Legal & General Group PlcBought 2,588 shares on 2/15/2023Ownership: 0.276%Toroso Investments LLCBought 1,738 shares on 2/15/2023Ownership: 0.083%Jane Street Group LLCBought 10,615 shares on 2/15/2023Ownership: 0.083%View All Institutional Transactions CLB Stock - Frequently Asked Questions Should I buy or sell Core Laboratories stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last twelve months. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CLB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares. View CLB analyst ratings or view top-rated stocks. What is Core Laboratories' stock price forecast for 2023? 4 Wall Street analysts have issued 1 year target prices for Core Laboratories' stock. Their CLB share price forecasts range from $20.00 to $26.00. On average, they anticipate the company's share price to reach $21.83 in the next twelve months. This suggests that the stock has a possible downside of 1.0%. View analysts price targets for CLB or view top-rated stocks among Wall Street analysts. How have CLB shares performed in 2023? Core Laboratories' stock was trading at $20.27 at the beginning of 2023. Since then, CLB stock has increased by 8.8% and is now trading at $22.05. View the best growth stocks for 2023 here. When is Core Laboratories' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023. View our CLB earnings forecast. How can I listen to Core Laboratories' earnings call? Core Laboratories will be holding an earnings conference call on Thursday, April 27th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link. How were Core Laboratories' earnings last quarter? Core Laboratories (NYSE:CLB) issued its earnings results on Thursday, February, 2nd. The oil and gas company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.19 by $0.01. The oil and gas company earned $127.57 million during the quarter, compared to the consensus estimate of $130.12 million. Core Laboratories had a net margin of 3.97% and a trailing twelve-month return on equity of 15.98%. The firm's revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.20 EPS. How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories? Core Laboratories declared a quarterly dividend on Wednesday, February 1st. Shareholders of record on Monday, February 13th will be paid a dividend of $0.01 per share on Monday, March 6th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.18%. The ex-dividend date is Friday, February 10th. Read our dividend analysis for CLB. What ETFs hold Core Laboratories' stock? ETFs with the largest weight of Core Laboratories (NYSE:CLB) stock in their portfolio include Cultivar ETF (CVAR), Invesco Dynamic Oil & Gas Services ETF (PXJ), Invesco S&P SmallCap Energy ETF (PSCE), SPDR S&P Oil & Gas Equipment & Services ETF (XES), iShares U.S. Oil Equipment & Services ETF (IEZ), VanEck Oil Services ETF (OIH), Direxion Daily Oil Services Bull 2X Shares (ONG) and Invesco S&P SmallCap 600 Equal Weight ETF (EWSC). Is Core Laboratories a good dividend stock? Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.19%. The dividend payout ratio is 9.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 3.67% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CLB. What guidance has Core Laboratories issued on next quarter's earnings? Core Laboratories updated its first quarter earnings guidance on Wednesday, February, 1st. The company provided earnings per share (EPS) guidance of $0.14-0.19 for the period, compared to the consensus estimate of $0.18. The company issued revenue guidance of $125-129 million, compared to the consensus revenue estimate of $127.42 million. What is David M. Demshur's approval rating as Core Laboratories' CEO? 60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD). What is Core Laboratories' stock symbol? Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB." Who are Core Laboratories' major shareholders? Core Laboratories' stock is owned by many different institutional and retail investors. Top institutional shareholders include Ariel Investments LLC (20.92%), Fred Alger Management LLC (8.31%), Earnest Partners LLC (7.71%), Boston Trust Walden Corp (4.25%), Van ECK Associates Corp (2.15%) and Congress Asset Management Co. MA (1.54%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Core Laboratories' stock price today? One share of CLB stock can currently be purchased for approximately $22.05. How much money does Core Laboratories make? Core Laboratories (NYSE:CLB) has a market capitalization of $1.03 billion and generates $489.73 million in revenue each year. The oil and gas company earns $19.45 million in net income (profit) each year or $0.41 on an earnings per share basis. How many employees does Core Laboratories have? The company employs 3,600 workers across the globe. How can I contact Core Laboratories? Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at investor.relations@corelab.com. This page (NYSE:CLB) was last updated on 4/1/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.